Metabolic and Bariatric Surgery · 1 November 2023

New Calculator Predicts Success of Bariatric Surgery in Comorbidity Remission

The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) developed a public tool, the Bariatric Surgical Risk/Benefit Calculator, to evaluate short-term surgery risks and long-term benefits for prospective adult bariatric surgery patients. This study assessed the calculator’s performance in predicting 1-year remission of comorbidities. The results indicate that the calculator effectively predicts comorbidity remission, offering a valuable resource for enhancing patient-clinician discussions and informed consent in clinical practice.

Journal Article by Grieco A, Huffman KM (…) Ko CY et 3 al. in Surg Obes Relat Dis

read the whole article in Surg Obes Relat Dis

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →